OCTOBER 2023LIFE SCIENCES REVIEW1ISSN 2831-8331OCTOBER - 23 - 2023EUROPE SPECIALLIFESCIENCESREVIEW.COMEDITIONBIOSIMILARS LEVERAGING TECHNOLOGICAL ADVANCEMENTS FOR DEVELOPING INNOVATIVE THERAPEUTICSBy Marc de Garidel, CEO and Interim Chairman, Abivax
Page 2 >